Intalere members to benefit through new agreement with Celltrion USA
Press releases may be edited for formatting or style | December 24, 2020
Business Affairs
St. Louis (December 22, 2020) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new pharmaceutical agreement with Celltrion USA.
Through this agreement Intalere members will receive negotiated pricing on pharmaceuticals and biosimilar products for the treatment of autoimmune diseases enabling patients from all over the world to benefit from a wide range of healthcare services and reduce the financial burden associated with healthcare services.
This contract is currently effective through October 31, 2025.
About Celltrion USA
Celltrion USA is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA cGMP and the EU GMP guidelines. Celltrion Healthcare endeavors to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries. For more information please visit: https://www.celltrion.com/en-us/home/index.
About Intalere
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.
Through this agreement Intalere members will receive negotiated pricing on pharmaceuticals and biosimilar products for the treatment of autoimmune diseases enabling patients from all over the world to benefit from a wide range of healthcare services and reduce the financial burden associated with healthcare services.
This contract is currently effective through October 31, 2025.
About Celltrion USA
Celltrion USA is committed to delivering innovative and affordable medications to promote patients’ access to advanced therapies. Its products are manufactured at state-of-the-art mammalian cell culture facilities, designed and built to comply with the US FDA cGMP and the EU GMP guidelines. Celltrion Healthcare endeavors to offer high-quality cost-effective solutions through an extensive global network that spans more than 110 different countries. For more information please visit: https://www.celltrion.com/en-us/home/index.
About Intalere
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.
You Must Be Logged In To Post A CommentRegistoO registro é gratuito e fácil. Aproveite os benefícios dos principais produtos novos e inovadores do mundo. Mercado de equipamentos médicos usados. Registrar agora! |
|